Evidence map›Paper›PMID 31212849›Full record

ArticleMolecules (Basel, Switzerland)2019

An Advanced In Silico Modelling of the Interaction between FSCPX, an Irreversible A

Adrienn Monika Szabo, Tamas Erdei, Gabor Viczjan, Rita Kiss, Judit Zsuga, Csaba Papp, Akos Pinter, Bela Juhasz, Zoltan Szilvassy, Rudolf Gesztelyi

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Adrienn Monika SzaboDepartment of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. szabo.adrienn23@gmail.com.
Tamas ErdeiDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. erdei.tamas@pharm.unideb.hu.
Gabor ViczjanDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. vicgabaa@gmail.com.
Rita KissDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. kiss.rita@med.unideb.hu.
Judit ZsugaDepartment of Health Systems Management and Quality Management for Health Care, Faculty of Public Health, University of Debrecen, H-4032 Debrecen, Hungary. zsuga.judit@med.unideb.hu.
Csaba PappDepartment of Health Systems Management and Quality Management for Health Care, Faculty of Public Health, University of Debrecen, H-4032 Debrecen, Hungary. dr.papp.csaba@gmail.com.
Akos PinterInstitute of Mathematics, Faculty of Science and Technology, University of Debrecen, H-4032 Debrecen, Hungary. zsuga.judit@med.unideb.hu.
Bela JuhaszDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. juhasz.bela@med.unideb.hu.
Zoltan SzilvassyDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. szilvassy.zoltan@med.unideb.hu.
Rudolf GesztelyiDepartment of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary. gesztelyi.rudolf@pharm.unideb.hu.
University of Debrecen · HU

Funding

Horizon 2020 Framework Programme EFOP-3.6.2-16-2017-00015
6 · The paper itself

Abstract

In earlier studies, we generated concentration-response (E/c) curves with CPA (

Indexed as

AdenosineAdenosine A1 Receptor AntagonistsAnimalsDose-Response Relationship, DrugGuinea PigsNucleobase Transport ProteinsReceptor, Adenosine A1Xanthines8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthineAdenosineAdenosine A1 Receptor AntagonistsNucleobase Transport ProteinsReceptor, Adenosine A1XanthinesA1 adenosine receptoradenosinecomputer simulationCPAFSCPXNBTIoperational model of agonismreceptorial responsiveness methodRRM

Identifiers

PMID31212849
PMCPMC6630508
OpenAlexW2951092937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.